Valuation: Yuhan Corporation

Market Cap 6,114B 4.31B 3.73B 3.49B 3.19B 6.01B 411B 6.1B 40.92B 16.06B 206B 16.19B 15.84B 685B P/E 2026 *
41.2x
P/E 2027 * 29.9x
Enterprise Value 6.03B 4.26M 3.68M 3.44M 3.15M 5.93M 406M 6.02M 40.38M 15.85M 203M 15.98M 15.63M 676M EV / Sales 2026 *
2.57x
EV / Sales 2027 * 2.33x
Free-Float
64.28%
Yield 2026 *
0.69%
Yield 2027 * 0.7%
1 day+1.74%
1 week+11.56%
Current month+11.56%
1 month+21.66%
3 months-5.31%
6 months-23.58%
Current year-27.05%
1 week 72,800
Extreme 72800
82,200
1 month 66,200
Extreme 66200
82,200
Current year 65,000
Extreme 65000
115,900
1 year 65,000
Extreme 65000
129,200
3 years 52,285.71
Extreme 52285.714285
166,900
5 years 47,571.43
Extreme 47571.428571
166,900
10 years 24,550.49
Extreme 24550.486545
166,900
Manager TitleAgeSince
Chief Executive Officer 71 2021-03-18
Director of Finance/CFO 58 -
President 67 2024-03-14
Director TitleAgeSince
Chairman 74 2021-03-18
Director/Board Member 71 2015-03-19
Director/Board Member 62 2020-02-29
Date Insider Type Main position Quantity % Market Cap.
6/30/25 Buy

Chairperson

200 0.0002%
6/25/25 Buy

Chief Executive Officer

720 0.0009%
6/24/25 Buy 231 0.0003%
Change 5-day change 1-year change 3-year change Capi.($)
+1.74%+11.56%-26.79%+10.24% 4.26B
+1.49%+1.87%+62.64%+23.29% 317B
-0.10%+0.74%+32.87%-13.03% 72.2B
-0.23%+23.76%+61.90%+131.25% 11.7B
+0.63%+0.31%-3.74%-4.44% 8.45B
+3.86%+12.28%-10.94%-10.67% 4.75B
-0.47%+21.53%+3.76%+49.73% 4.38B
-1.06%+1.29%+14.85%+46.57% 2.77B
+0.80%+1.11%+1.98%+1.03% 2.26B
-1.48%+10.73%-15.80%+38.21% 1.95B
Average +0.35%+8.19%+12.07%+27.22% 43B
Weighted average by Cap. +1.11%+0.33%+53.03%+19.45%

Financials

2026 *2027 *
Net sales 2,350B 1.66B 1.43B 1.34B 1.23B 2.31B 158B 2.35B 15.73B 6.17B 79.08B 6.22B 6.09B 263B 2,556B 1.8B 1.56B 1.46B 1.33B 2.51B 172B 2.55B 17.1B 6.71B 86B 6.77B 6.62B 286B
Net income 154B 108M 93.86M 87.73M 80.18M 151M 10.34B 153M 1.03B 404M 5.17B 407M 398M 17.23B 206B 145M 126M 118M 107M 202M 13.85B 206M 1.38B 541M 6.93B 545M 533M 23.08B
Net Debt -80.13B -56.51M -48.92M -45.73M -41.79M -78.76M -5.39B -79.99M -536M -210M -2.7B -212M -208M -8.98B -162B -114M -98.8M -92.35M -84.4M -159M -10.88B -162M -1.08B -425M -5.45B -429M -419M -18.14B
Logo Yuhan Corporation
Yuhan Corp is a Korea-based company primarily engaged in the manufacture and sale of pharmaceuticals. The Company operates its business through three segments. The Pharmaceutical Business segment manufactures and sells non-prescription drugs, such as analgesics, anti-inflammatory drugs, probiotics, nutritional supplements, and wound-healing agents, as well as prescription drugs, including treatments for diabetes, hyperlipidemia, hypertension, hepatitis, acquired immunodeficiency syndrome (AIDS), bone marrow cancer, cough suppressants, and breast cancer. The Overseas Business segment engages in the export of AIDS treatment intermediates. The Healthcare Business segment provides household goods, such as bleach. Additionally, the Company sells licenses. The Company sells its products in both domestic and overseas markets.
Employees
2,087
Date Price Change Volume
26-08-09 82,000.00 +1.74% 200,191
26-08-07 ₩80,600.00 +3.60% 310,697
26-08-06 ₩77,800.00 +3.60% 267,750
26-08-05 ₩75,100.00 +0.40% 238,250
26-08-04 ₩74,800.00 +1.63% 216,144
Trader
Investor
Global
Quality
ESG MSCI
AA
Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
18
Last Close Price
82,000.00KRW
Average target price
121,777.78KRW
Spread / Average Target
+48.51%

Quarterly revenue - Rate of surprise

  1. Stock Market
  2. Stocks
  3. A000100 Stock